Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

of the patients who have developed rhabdomyolysis on therapy with lovastatin have had complicated medical histories, including renal insufficiency usually as a consequence of long-standing diabetes mellitus. Such patients merit closer monitoring. Therapy with lovastatin should be temporarily stopped a few days prior to elective major surgery and when any major medical or surgical condition supervenes.

The risk of myopathy/rhabdomyolysis is increased by concomitant use of lovastatin with the following:

Potent inhibitors of CYP3A4: Lovastatin, like several other inhibitors of HMG-CoA reductase, is a substrate of cytochrome P450 3A4 (CYP3A4). When lovastatin is used with a potent inhibitor of CYP3A4, elevated plasma levels of HMG-CoA reductase inhibitory activity can increase the risk of myopathy and rhabdomyolysis, particularly with higher doses of lovastatin.

The use of lovastatin concomitantly with the potent CYP3A4 inhibitors itraconazole, ketoconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, or large quantities of grapefruit juice (>1 quart daily) should be avoided. Concomitant use of other medicines labeled as having a potent inhibitory effect on CYP3A4 should be avoided unless the benefits of combined therapy outweigh the increased risk. If treatment with itraconazole, ketoconazole, erythromycin, clarithromycin or telithromycin is unavoidable, therapy with lovastatin should be suspended during the course of treatment.

Gemfibrozil, particularly with higher doses of lovastatin: The dose of lovastatin should not exceed 20 mg daily in patients receiving concomitant medication with gemfibrozil. The combined use of lovastatin with gemfibrozil should be avoided, unless the benefits are likely to outweigh the increased risks of this drug combination.

Other lipid-lowering drugs (other fibrates or Greater Than or Equal To 1 g/day of niacin): The dose of lovastatin should not exceed 20 mg daily i
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... (PRWEB) May 04, 2015 The Lymphoma ... devoted exclusively to funding innovative lymphoma research and serving ... programs, outreach initiatives and patient services – is set ... historic Mayfair Farms in West Orange, NJ on June ... $500,000 for innovative research programs through LRF. , This ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 In May of ... took his own life. In the wake of this tragedy, ... Silent, an organization that exposes the grim reality of bullying ... a platform for Kirk and Laura to share their story ... tragedy from happening to another family — a mission that ...
(Date:5/4/2015)... York, NY (PRWEB) May 04, 2015 Ticket ... 2015 International Champions Cup (ICC) . While the ... world and is held every four years, the International Champions ... year, the tournament saw the all-time attendance record for soccer ... Madrid from the Big House at the University of Michigan. ...
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... of atorvastatin, a type of cholesterol-lowering drug, found that ... levels, it did inhibit expression of cellular markers of ... Since immune activation and inflammation are associated with progression ... may inhibit disease progression and help in the infection,s ...
... 16 (HealthDay News) -- The way women draw themselves ... researchers suggest. They found that women with anorexia ... without eating disorders. The study, by Israeli researchers, ... women with no eating disorder, half of them overweight ...
... 16 (HealthDay News) -- Americans living in parts of ... physically active in their free time, according to federal ... the least likely to be physically active during leisure ... Physical inactivity rates are 29.2 percent or greater for ...
... A University of Minnesota research team was recently ... from the National Science Foundation,s Cyber-Enabled Discovery and ... vision algorithms that will assist with the early ... such as autism, attention deficit disorder (ADD) and ...
... dropping out are particularly sensitive to a handful of critical ... a study led by Michigan State University scholars. Surprisingly, ... and students, failure to get their intended major did not ... said Tim Pleskac, MSU assistant professor of psychology and lead ...
... of children developmental disabilities such as Down syndrome and ... lower school performance, according to a new study led ... "When a child has a disability, all ... lead author Debra Lobato, Ph.D., of the Bradley Hasbro ...
Cached Medicine News:Health News:Trial suggests statin may affect markers associated with progression of HIV 2Health News:Self-Drawings May Reveal Hidden Eating Disorders 2Health News:Appalachia, the South Home to Least-Active Americans: CDC 2Health News:University of Minnesota researchers study the use of computer vision to diagnose mental disorders 2Health News:MSU-led study identifies risks for quitting college 2Health News:Latino siblings of children with developmental disabilities at risk 2Health News:Latino siblings of children with developmental disabilities at risk 3
(Date:5/4/2015)... , May 4, 2015 Unchained Labs, ... out to this year,s PEGS conference and launches the ... system for biologics. PEGS: The Essential Protein Engineering Summit ... 4-8, 2015. The UNit lets drug discovery ... other tool out there. Its 7 applications, 144 sample ...
(Date:5/4/2015)... , May 4, 2015 ... of Michael Williams into the newly ... Williams is a senior pharmaceutical executive with world-class ... also long and distinguished service at industry leaders ... expertise spans a broad range of therapeutic areas, ...
(Date:5/4/2015)... 4, 2015 CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to treat critically-ill and ... report Q1 2015 financial results after the market ... CytoSorbents, management will host a live conference ... operational and financial progress during Q1 2015 followed ...
Breaking Medicine Technology:Unchained Labs Lets the UNit Loose 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3
... Inc. (OTCPK: ILNS) announces that Dr. Daniel G. ... the 10TH Annual BIO Investor Forum.  Hosted by ... seeking capital, distribution, and visibility with investors and ... healthcare companies. The meeting will take place January ...
... Calif., Dec. 14, 2011  AtheroNova Inc. (OTCBB: AHRO) ... and development of compounds to regress atherosclerotic plaque ... I and Phase II protocol outlines, based on ... New Drug) meeting with the U.S. Food and ...
Cached Medicine Technology:Intellect Neurosciences, Inc. to Present at OneMedForum 2Intellect Neurosciences, Inc. to Present at OneMedForum 3FDA Agrees With AtheroNova's Clinical Development Plan as Proposed 2FDA Agrees With AtheroNova's Clinical Development Plan as Proposed 3
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology....
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
Medicine Products: